Transcutaneous bowel sonography for inflammatory bowel disease is sensitive and specific when performed in a nonexpert low-volume North American center.

Objectives: Transcutaneous bowel sonography is a nonionizing imaging modality used in inflammatory bowel disease. Although available in Europe, its uptake in North America has been limited. Since the accuracy of bowel sonography is highly operator dependent, low-volume centers in North America may not achieve the same diagnostic accuracy reported in the European literature.

Discrepancy between ultrasound and final pathologic measurements in thyroid cancer.

Background: The size of the malignancy in well-differentiated thyroid carcinoma (WDTC) is an important factor in patient risk stratification. Final pathologic measurements are currently used for treatment decisions. Measurements are made by both ultrasonography and on final pathology and should, theoretically, agree with each other.